iScience (Feb 2023)

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization

  • Sho Miyamoto,
  • Takeshi Arashiro,
  • Akira Ueno,
  • Takayuki Kanno,
  • Shinji Saito,
  • Harutaka Katano,
  • Shun Iida,
  • Akira Ainai,
  • Seiya Ozono,
  • Takuya Hemmi,
  • Yuichiro Hirata,
  • Saya Moriyama,
  • Ryutaro Kotaki,
  • Hitomi Kinoshita,
  • Souichi Yamada,
  • Masaharu Shinkai,
  • Shuetsu Fukushi,
  • Yoshimasa Takahashi,
  • Tadaki Suzuki

Journal volume & issue
Vol. 26, no. 2
p. 105969

Abstract

Read online

Summary: The immune responses to SARS-CoV-2 variants in COVID-19 cases are influenced by various factors including pre-existing immunity via vaccination and prior infection. Elucidating the drivers for upgrading neutralizing activity to SARS-CoV-2 in COVID-19 cases with pre-existing immunity will aid in improving COVID-19 booster vaccines with enhanced cross-protection against antigenically distinct variants, including the Omicron sub-lineage BA.4/5. This study revealed that the magnitude and breadth of neutralization activity to SARS-CoV-2 variants after breakthrough infections are determined primarily by upper respiratory viral load and vaccination-infection time interval. Extensive neutralizing breadth, covering even the most antigenically distant BA.4/5, was observed in cases with higher viral load and longer time intervals. Antigenic cartography depicted a critical role of the time interval in expanding the breadth of neutralization to SARS-CoV-2 variants. Our results illustrate the importance of dosing interval optimization as well as antigen design in developing variant-proof booster vaccines.

Keywords